Table 1B. Datasets used for independent validation of PDAC classifier.
| Phase I Validation Sets: | |||||
|---|---|---|---|---|---|
| Dataset | Normal | Tumor | Sample Type | Platform | Accession # |
| V1 | 7 | 25 | Whole Tissue | Plus 2.0 | GSE32676 |
| V2 | 45 | 45 | Whole Tissue | Gene St 1.0 | GSE28735 |
| V3 | 0 | 36 | Whole Tissue (Xenografts in duplicate) | Plus 2.0 | GSE9599 |
| V4 | 0 | 18 | Microdissected | Plus 2.0 | E-MEXP-2894 |
| V5 | 145 | 0 | Whole Tissue & Cell Lines (most 3 replicates) | U133A | E-TABM-145 |
| Phase II Validation Sets: | |||||
| Dataset | Group | Pancreatic Tumor | Sample Type | Platform | Accession # |
| P1 | 6 (Normal) | 15 (IPMA, IPMC, IPMN) | Microdissected | Plus 2.0 | GSE19650 |
| P2 | 9 (Pancreatitis) | 6 | Microdissected | U133A | E-MEXP-1121 |
| C1 | 4 (Normal) | 28 | Whole Tissue | Agilent | GSE11838 |
| M1 | 25 (other Cancers) | 11 | Whole Tissue | U133A | GSE12630 |